Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung Cancer

SIMPLE SUMMARY: In clinical settings, patients receiving immune checkpoint inhibitors (ICIs) have different treatment criteria than those enrolled in clinical trials. There are concerns regarding the efficacy of ICIs in older adults due to age-associated decline in the immune system, and no study ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Ham, Ahrong, Lee, Young, Kim, Hae Su, Lim, Taekyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453652/
https://www.ncbi.nlm.nih.gov/pubmed/37627226
http://dx.doi.org/10.3390/cancers15164198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453652/
https://www.ncbi.nlm.nih.gov/pubmed/37627226
http://dx.doi.org/10.3390/cancers15164198

Ejemplares similares